“Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD)” (2018) Biomolecules and Biomedicine, 18(2), pp. 126–131. doi:10.17305/bjbms.2018.2942.